VITAMIN IV THERAPY CLINIC BUSINESS PLAN

I. Executive Summary

Company Description

Our company name references clinical vitality and wellness and signals a medical-first approach to rapid physiological recovery. We operate in the healthcare and wellness sector, offering medical-grade intravenous (IV) hydration and nutrient therapy in a luxury clinic setting launching in 2026 in a major U.S. urban center. We deliver 100% absorption of vitamins and minerals via customized IV treatments overseen by a Medical Director and administered by Nurse Practitioners and Registered Nurses. One-liner: medical precision in a high-end spa environment.

Core activities include patient intake and assessment, personalized treatment formulation, IV administration, and post-care monitoring in a tranquil facility. We target affluent urban professionals and health-conscious adults seeking proactive performance and rapid recovery. Short-term goal: open the flagship clinic and achieve clinical and regulatory accreditation in year one. Long-term goal: become the region’s leading destination for proactive health management and expand via additional urban locations and clinician-led service lines. One-liner: clinical results, delivered with luxury service.

Problem

Modern urban lifestyles produce high stress and frequent nutrient shortfalls that lead to chronic fatigue, weakened immune response, and slower physical recovery after exertion.

Oral supplements often fail to deliver reliable, rapid results because absorption through the digestive tract is limited; customers seek faster, measurable improvement. There is a gap for medically supervised, fast-acting nutrient delivery that bypasses digestion.

Existing wellness options rarely combine licensed medical oversight with a tranquil, high-end environment for proactive recovery—creating unmet demand for a premier IV wellness clinic that provides 100% absorption and immediate physiological benefits.

Solution

Busy professionals and athletes face chronic fatigue, nutrient gaps, and weakened immunity that oral supplements often can't fix—oral absorption can be as low as 10–20%. We deliver customized, clinically administered IV nutrient drips—including Immunity Boost (vitamin C, zinc, electrolytes) and Energy Recharge (B-complex, magnesium, fluids)—to bypass the digestive tract, provide rapid bioavailability, and produce measurable short-term improvements in hydration, energy, and immune support in a serene, spa-like setting under licensed medical staff.

Clinically administered IV nutrient drips that give fast, noticeable hydration and energy benefits under licensed supervision.

Mission Statement

Our mission is to empower individuals to achieve peak vitality through personalized, medical-grade IV therapies delivered in a tranquil, professional setting that bridges clinical science and luxury wellness. We commit to safe, effective nutrient delivery, restorative experiences, and continuous innovation so our community can combat modern stress and proactively manage their health.

Key Success Factors

Success depends on staffing, atmosphere, utilization, partnerships, and regulatory compliance aligned to our value-based pricing and target market.

• Recruit and retain licensed clinical team — Lead RN plus Nurse Practitioners staffed and credentialed.
• Maintain premium spa-like atmosphere — facility, service, and experience that justify value pricing.
• Grow utilization from 40% (2026) to 85% (2030) — demand via targeted marketing and retention.
• Build referral pipeline via strategic partnerships — local high-end fitness centers and corporate wellness programs.
• Follow medical safety and state regulations — protocols, reporting, and liability controls to protect reputation.

Financial Summary

The clinic launches in 2026 with initial capex of $193,000, reaches breakeven in March 2027, and achieves strong EBITDA growth and payback within 38 months.

Financial requirements: $193,000 capex plus operating cash to maintain a minimum cash balance of $477,000; expected payback 38 months and reported IRR ~4%.

Overall outlook: profitable by year two with accelerating EBITDA and a strong return on equity.

Funding Requirements

Launching in 2026 with Year‑1 EBITDA of -$241,000, the clinic needs upfront capital for a high‑end fit‑out and equipment (total capex $193,000), working capital to cover operating losses to breakeven in Mar‑2027 and reach a Dec‑2027 cash buffer, and is forecast to deliver EBITDA of $533,000 in Year 3 and $1,590,000 in Year 5 with a 3.2 ROE and 38‑month payback.